Back
General Mills Vs. Janux Therapeutics Industry Stock Comparison
Buy
58
GIS
General Mills
Last Price:
71.43
Seasonality Move:
2.53%
Sell
37
JANX
Janux Therapeutics
Last Price:
47.99
Seasonality Move:
8.69%
Buy
58
General Mills (GIS)
is a Buy
Is General Mills a Buy, Sell or Hold?
- The current General Mills [GIS] share price is $71.24. The Score for GIS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- GIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $47.10. The Score for JANX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GIS Stock Price Chart
What is General Mills's stock price today?
-
The General Mills share price today is $71.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GIS is experiencing slight buying pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $47.10
The current trend is moderately bearish and JANX is experiencing slight selling pressure.
GIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 57.5 | Buy |
| Chaikin Money Flow: | 639920 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.08 - 71.22) | Buy |
| Bollinger Bands (100): | (63.94 - 69.6) | Buy |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.72 | Buy |
| Relative Strength Index (14 RSI): | 44.16 | Sell |
| Chaikin Money Flow: | -317532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.78 - 57.84) | Sell |
| Bollinger Bands (100): | (12.31 - 49.41) | Buy |
GIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.56 | Buy |
| 20-day SMA: | 70.53 | Buy |
| 50-day SMA: | 69.23 | Buy |
| 200-day SMA: | 66.37 | Buy |
| 8-day EMA: | 70.68 | Buy |
| 20-day EMA: | 70.26 | Buy |
| 50-day EMA: | 69.09 | Buy |
| 200-day EMA: | 68.74 | Buy |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.54 | Sell |
| 20-day SMA: | 52.99 | Sell |
| 50-day SMA: | 45.97 | Buy |
| 200-day SMA: | 20.17 | Buy |
| 8-day EMA: | 49.81 | Sell |
| 20-day EMA: | 50.9 | Sell |
| 50-day EMA: | 45.06 | Buy |
| 200-day EMA: | 26.54 | Buy |
General Mills Earnings Growth & GIS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.26 per share, and an increase next year of $0.18 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
General Mills Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||